Mafalda Bourbon
Impact in
- Surgery top 0.5%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
-
- Lipid metabolism and disorders
- Cardiovascular Health and Risk Factors
Papers in
- Surgery 88
- Lipoproteins and Cardiovascular Health 88
- Cholesterol and Lipid Metabolism 5
-
- Lipid metabolism and disorders 6
- Cardiomyopathy and Myosin Studies 4
- Cardiovascular Health and Risk Factors 4
- Co-authors
- Ana Catarina Alves (53 shared papers)Ana Margarida Medeiros (30 shared papers)Anne K. Soutar (8 shared papers)Cesar Augusto Martín (8 shared papers)Joana Rita Chora (13 shared papers)Aitor Etxebarria (5 shared papers)Asier Benito‐Vicente (7 shared papers)Helena Cortez‐Pinto (7 shared papers)
- Journals
- Atherosclerosis (23 papers)Journal of clinical lipidology (5 papers)Genetics in Medicine (4 papers)Current Opinion in Lipidology (4 papers)The Lancet (3 papers)
- Partner nations
- PortugalUnited KingdomSpain
In The Last Decade
Mafalda Bourbon
119 papers receiving 3.3k citations
Mafalda Bourbon's Hit Papers
Peers
Comparison fields: 5 of 94
- Surgery 2.7k
- Cardiology and Cardiovascular Medicine 254
- Drug Discovery 3
- Genetics 288
- Aquatic Science 42
Countries citing papers authored by Mafalda Bourbon
This map shows the geographic impact of Mafalda Bourbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mafalda Bourbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mafalda Bourbon more than expected).
Fields of papers citing papers by Mafalda Bourbon
This network shows the impact of papers produced by Mafalda Bourbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mafalda Bourbon. The network helps show where Mafalda Bourbon may publish in the future.
Co-authors
The 25 scholars most cited alongside Mafalda Bourbon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Genetic Testing for Familial Hypercholesterolemia Hit paper breakdown → | 2018 | 463 |
| 2 | Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Hit paper breakdown → | 2021 | 232 |
| 3 | 2018 | 191 | |
| 4 | 2015 | 148 | |
| 5 | Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study Hit paper breakdown → | 2022 | 146 |
| 6 | 2021 | 125 | |
| 7 | 2017 | 107 | |
| 8 | 2016 | 100 | |
| 9 | 2015 | 99 | |
| 10 | 2018 | 90 | |
| 11 | 2007 | 80 | |
| 12 | 2013 | 75 | |
| 13 | 2019 | 73 | |
| 14 | 2013 | 69 | |
| 15 | 1999 | 67 | |
| 16 | 2001 | 59 | |
| 17 | 2017 | 59 | |
| 18 | 2018 | 51 | |
| 19 | 2019 | 51 | |
| 20 | 2010 | 48 |
About Mafalda Bourbon
Mafalda Bourbon is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Genetics, Pharmacology and Epidemiology, having authored 125 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (88 papers), Genomics and Rare Diseases (8 papers), Liver Disease Diagnosis and Treatment (6 papers), Lipid metabolism and disorders (6 papers), Cholesterol and Lipid Metabolism (5 papers), Cardiomyopathy and Myosin Studies (4 papers), Cardiovascular Health and Risk Factors (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Surgery (2.7k citations), Cardiology and Cardiovascular Medicine (254 citations), Drug Discovery (3 citations), Genetics (288 citations) and Aquatic Science (42 citations). Mafalda Bourbon has collaborated with scholars based in Portugal, United Kingdom and Spain. Frequent co-authors include Ana Catarina Alves, Ana Margarida Medeiros, Anne K. Soutar, Cesar Augusto Martín, Joana Rita Chora, Aitor Etxebarria, Asier Benito‐Vicente, Helena Cortez‐Pinto, Steve Eric Humphries and Sofia C. Carvalhana. Their work appears in journals such as Atherosclerosis, Journal of clinical lipidology, Genetics in Medicine, Current Opinion in Lipidology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.